PK/PD Study of 2 Agalsidase Formulations in Single Dose of 1 mg/kg Administered to Healthy Volunteers as IV Infusion
Clinical trial NCT05343715 · COMPLETED
Trial details
- NCT number
- NCT05343715
- Sponsor
- Bio Sidus SA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-23
- Primary completion
- 2022-03-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.